Global G-CSF and G-CSF Biosimilars Market Research Report 2021

1 G-CSF and G-CSF Biosimilars Market Overview

• 1.1 Product Overview and Scope of G-CSF and G-CSF Biosimilars
• 1.2 G-CSF and G-CSF Biosimilars Segment by Type
  • 1.2.1 Global G-CSF and G-CSF Biosimilars Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Blood Disorders
  • 1.2.3 Oncology Diseases
  • 1.2.4 Chronic And Autoimmune Diseases
  • 1.2.5 Growth Hormone Deficiencies
• 1.3 G-CSF and G-CSF Biosimilars Segment by Application
  • 1.3.1 G-CSF and G-CSF Biosimilars Sales Comparison by Application: (2021-2027)
  • 1.3.2 Human Growth Hormone
  • 1.3.3 Erythropoietin
  • 1.3.4 Monoclonal Antibodies
  • 1.3.5 Insulin
  • 1.3.6 Interferon
• 1.4 Global G-CSF and G-CSF Biosimilars Market Size Estimates and Forecasts
  • 1.4.1 Global G-CSF and G-CSF Biosimilars Revenue 2016-2027
  • 1.4.2 Global G-CSF and G-CSF Biosimilars Sales 2016-2027
  • 1.4.3 G-CSF and G-CSF Biosimilars Market Size by Region: 2016 Versus 2021 Versus 2027

2 G-CSF and G-CSF Biosimilars Market Competition by Manufacturers

• 2.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global G-CSF and G-CSF Biosimilars Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers G-CSF and G-CSF Biosimilars Manufacturing Sites, Area Served, Product Type
• 2.5 G-CSF and G-CSF Biosimilars Market Competitive Situation and Trends
  • 2.5.1 G-CSF and G-CSF Biosimilars Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest G-CSF and G-CSF Biosimilars Players Market Share by Revenue
  • 2.5.3 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 G-CSF and G-CSF Biosimilars Retrospective Market Scenario by Region

• 3.1 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  • 3.3.1 North America G-CSF and G-CSF Biosimilars Sales by Country
  • 3.3.2 North America G-CSF and G-CSF Biosimilars Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  • 3.4.1 Europe G-CSF and G-CSF Biosimilars Sales by Country
  • 3.4.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Region
  • 3.5.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region
  • 3.5.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  • 3.6.1 Latin America G-CSF and G-CSF Biosimilars Sales by Country
  • 3.6.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country
  • 3.7.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global G-CSF and G-CSF Biosimilars Historic Market Analysis by Type

• 4.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2016-2021)
• 4.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2016-2021)
• 4.3 Global G-CSF and G-CSF Biosimilars Price by Type (2016-2021)

5 Global G-CSF and G-CSF Biosimilars Historic Market Analysis by Application

• 5.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2016-2021)
• 5.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2016-2021)
• 5.3 Global G-CSF and G-CSF Biosimilars Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Pfizer
  • 6.1.1 Pfizer Corporation Information
  • 6.1.2 Pfizer Description and Business Overview
  • 6.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Pfizer Product Portfolio
  • 6.1.5 Pfizer Recent Developments/Updates
• 6.2 Novartis
  • 6.2.1 Novartis Corporation Information
  • 6.2.2 Novartis Description and Business Overview
  • 6.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Novartis Product Portfolio
  • 6.2.5 Novartis Recent Developments/Updates
• 6.3 Roche
  • 6.3.1 Roche Corporation Information
  • 6.3.2 Roche Description and Business Overview
  • 6.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Roche Product Portfolio
  • 6.3.5 Roche Recent Developments/Updates
• 6.4 Merck & Co.
  • 6.4.1 Merck & Co. Corporation Information
  • 6.4.2 Merck & Co. Description and Business Overview
  • 6.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck & Co. Product Portfolio
  • 6.4.5 Merck & Co. Recent Developments/Updates
• 6.5 Sanofi
  • 6.5.1 Sanofi Corporation Information
  • 6.5.2 Sanofi Description and Business Overview
  • 6.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Sanofi Product Portfolio
  • 6.5.5 Sanofi Recent Developments/Updates
• 6.6 Johnson & Johnson
  • 6.6.1 Johnson & Johnson Corporation Information
  • 6.6.2 Johnson & Johnson Description and Business Overview
  • 6.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Johnson & Johnson Product Portfolio
  • 6.6.5 Johnson & Johnson Recent Developments/Updates
• 6.7 Gilead Science
  • 6.6.1 Gilead Science Corporation Information
  • 6.6.2 Gilead Science Description and Business Overview
  • 6.6.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Gilead Science Product Portfolio
  • 6.7.5 Gilead Science Recent Developments/Updates
• 6.8 GlaxoSmithKline
  • 6.8.1 GlaxoSmithKline Corporation Information
  • 6.8.2 GlaxoSmithKline Description and Business Overview
  • 6.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 GlaxoSmithKline Product Portfolio
  • 6.8.5 GlaxoSmithKline Recent Developments/Updates
• 6.9 AbbVie
  • 6.9.1 AbbVie Corporation Information
  • 6.9.2 AbbVie Description and Business Overview
  • 6.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 AbbVie Product Portfolio
  • 6.9.5 AbbVie Recent Developments/Updates
• 6.10 Amgen
  • 6.10.1 Amgen Corporation Information
  • 6.10.2 Amgen Description and Business Overview
  • 6.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Amgen Product Portfolio
  • 6.10.5 Amgen Recent Developments/Updates
• 6.11 AstraZeneca
  • 6.11.1 AstraZeneca Corporation Information
  • 6.11.2 AstraZeneca G-CSF and G-CSF Biosimilars Description and Business Overview
  • 6.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 AstraZeneca Product Portfolio
  • 6.11.5 AstraZeneca Recent Developments/Updates
• 6.12 Bayer
  • 6.12.1 Bayer Corporation Information
  • 6.12.2 Bayer G-CSF and G-CSF Biosimilars Description and Business Overview
  • 6.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Bayer Product Portfolio
  • 6.12.5 Bayer Recent Developments/Updates

7 G-CSF and G-CSF Biosimilars Manufacturing Cost Analysis

• 7.1 G-CSF and G-CSF Biosimilars Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
• 7.4 G-CSF and G-CSF Biosimilars Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 G-CSF and G-CSF Biosimilars Distributors List
• 8.3 G-CSF and G-CSF Biosimilars Customers

9 G-CSF and G-CSF Biosimilars Market Dynamics

• 9.1 G-CSF and G-CSF Biosimilars Industry Trends
• 9.2 G-CSF and G-CSF Biosimilars Growth Drivers
• 9.3 G-CSF and G-CSF Biosimilars Market Challenges
• 9.4 G-CSF and G-CSF Biosimilars Market Restraints

10 Global Market Forecast

• 10.1 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Type (2022-2027)
• 10.2 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Application (2022-2027)
• 10.3 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List